Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protection. Racine JJ, Dwyer JR, Chapman HD, Bell A, et al. J Immunol 2025 Aug 12:vkaf189. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Racine JJ, Dwyer JR, Chapman HD, Bell A, et al. Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protection. J Immunol 2025 Aug 12:vkaf189. doi: 10.1093.
PMID: 40796308